SciSparc Grants an Exclusive License for the Sales of CannAmide on the Amazon Marketplace in Canada to SciSparc Nutraceuticals
SPRC Stock | USD 0.31 0.02 6.90% |
About 63% of all Scisparc's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Scisparc suggests that some traders are interested. The current market sentiment, together with Scisparc's historical and current headlines, can help investors time the market. In addition, many technical investors use Scisparc stock news signals to limit their universe of possible portfolio assets.
TEL AVIV, Israel, June 07, 2023 SciSparc Ltd. , a specialty clinical-stage pharmaceutical...
Read at globenewswire.com
![]() |
Scisparc Current Investor Sentiment
Comfort Level 63
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Scisparc's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Scisparc.
News SentimentBullish | Hype SentimentBullish | Insider SentimentWaiting |
Scisparc Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Scisparc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Scisparc Fundamental Analysis
We analyze Scisparc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scisparc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scisparc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Scisparc is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Scisparc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scisparc stock to make a market-neutral strategy. Peer analysis of Scisparc could also be used in its relative valuation, which is a method of valuing Scisparc by comparing valuation metrics with similar companies.
Peers
Scisparc Related Equities
ZVSA | ZyVersa Therapeutics | 15.79 | ||||
TIL | Instil Bio | 13.46 | ||||
CTMX | CytomX Therapeutics | 5.00 | ||||
NUVB | Nuvation Bio | 2.73 | ||||
HOTH | Hoth Therapeutics | 2.35 | ||||
KPRX | Kiora Pharmaceuticals | 1.35 | ||||
CVKD | Cadrenal Therapeutics, | 2.04 | ||||
CDIO | Cardio Diagnostics | 2.32 | ||||
ASMB | Assembly Biosciences | 2.41 | ||||
QNRX | Quoin Pharmaceuticals | 3.20 | ||||
UNCY | Unicycive Therapeutics | 3.28 | ||||
VRAX | Virax Biolabs | 7.62 | ||||
REVB | Revelation Biosciences | 14.98 |
Complementary Tools for Scisparc Stock analysis
When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |